The real question isn't whether compounded versions contain semaglutideit's whether they deliver it with the accuracy, purity, and safety testing that clinical results depend on
But before starting any treatment, its important to understand how your body might respond
In the class of incretin mimetics, factors like risk of severe heart disease, heart disease history (former heart attack or stroke), A1C and weight loss needs, costs and insurance coverage, and patient preference are all important considerations when determining which drug to use
Clinical Trials on GLP-1 Single Agonists Liraglutide: The First GLP-1RA Approved for Adolescent Obesity Liraglutide (Saxenda ) was the first glucagon-like peptide-1 receptor agonist (GLP-1RA) approved for the management of obesity in adolescent populations
And as with any medication, there are potential complications and side effects based on your unique body and health
The amylin pathway adds satiety more than it adds nausea which is the relevant data point for the reta+cagri layering question